TRANSACTION CO.,Ltd.
TRANSACTION CO.,Ltd. (7818.T) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for TRANSACTION CO.,Ltd. (7818.T), featuring income statements, balance sheets, and cash flow data.
TRANSACTION CO.,Ltd. (7818.T) Income Statement & Financial Overview
Analyze TRANSACTION CO.,Ltd.’s 7818.T earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $6.40B | $7.11B | $6.14B | $6.14B |
| Cost of Revenue | $3.98B | $4.30B | $3.69B | $3.71B |
| Gross Profit | $2.43B | $2.80B | $2.45B | $2.43B |
| Gross Profit Ratio | $0.38 | $0.39 | $0.40 | $0.40 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $9.00M |
| SG&A Expenses | $1.25B | $1.26B | $1.19B | $1.12B |
| Operating Expenses | $1.25B | $1.26B | $1.20B | $1.13B |
| Total Costs & Expenses | $5.22B | $5.56B | $4.90B | $4.85B |
| Interest Income | $52.22M | $0.00 | $46.13M | $46.20M |
| Interest Expense | $509000.00 | $0.00 | $663000.00 | $934000.00 |
| Depreciation & Amortization | $56.22M | $44.25M | $58.05M | $42.74M |
| EBITDA | $1.45B | $1.59B | $1.52B | $1.35B |
| EBITDA Ratio | $0.23 | $0.22 | $0.25 | $0.22 |
| Operating Income | $1.18B | $1.54B | $1.25B | $1.30B |
| Operating Income Ratio | $0.18 | $0.22 | $0.20 | $0.21 |
| Other Income/Expenses (Net) | $216.61M | $49.00M | $212.36M | $12.46M |
| Income Before Tax | $1.40B | $1.59B | $1.46B | $1.31B |
| Income Before Tax Ratio | $0.22 | $0.22 | $0.24 | $0.21 |
| Income Tax Expense | $475.48M | $548.00M | $449.07M | $450.48M |
| Net Income | $921.17M | $1.04B | $1.01B | $858.91M |
| Net Income Ratio | $0.14 | $0.15 | $0.16 | $0.14 |
| EPS | $31.94 | $36.24 | $34.96 | $29.49 |
| Diluted EPS | $31.94 | $36.24 | $34.96 | $29.49 |
| Weighted Avg Shares Outstanding | $28.84M | $28.84M | $28.96M | $29.13M |
| Weighted Avg Shares Outstanding (Diluted) | $28.84M | $28.84M | $28.96M | $29.13M |
The company's financials show resilient growth, with revenue advancing from $6.14B in Q3 2024 to $6.40B in Q2 2025. Gross profit remained healthy with margins at 38% in Q2 2025 compared to 40% in Q3 2024. Operating income hit $1.18B last quarter, sustaining a consistent 18% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $1.45B. Net income dropped to $921.17M, while earnings per share reached $31.94. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan